Cogent Biosciences COGT
NASDAQ COGT
$31.59 -0.43 (-1.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Non Operating Income (2017 - 2026)

Updated

Cogent Biosciences (COGT) posted Non Operating Income of $6.23 million for Q2 2026, up 203.6% from $2.05 million a year earlier but down 0.4% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Non Operating Income (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Cogent Biosciences was $11.91 million, down 23.6% year-over-year; for FY2025, it was $4.43 million, down 78.0% from FY2024.

  • Annual Non Operating Income shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
  • In prior years, Cogent Biosciences' Non Operating Income was $20.08 million in FY2024 (+27.7%), $15.72 million in FY2023 (+106.9%), $7.6 million in FY2022 (+131.8%) and $3.28 million in FY2021 (-55.6%).
  • Quarterly Non Operating Income has run from a low of -$3 million in Q4 2025 to a high of $6.26 million in Q1 2026 over five years.
  • On a year-over-year basis, Non Operating Income increased in four of the last seven quarters, with growth averaging 34.5%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q4 2021, with growth of 516.9%; the weakest was Q3 2021, with a decline of 89.8%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $6.26 million (Q1 2026), -$3 million (Q4 2025) and $2.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cogent Biosciences 5.49 Bn 5.49 Bn - 6.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.23 Mn
Mar 31, 2026 6.26 Mn
Dec 31, 2025 -3.00 Mn
Sep 30, 2025 2.43 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 2.95 Mn
Dec 31, 2024 5.81 Mn
Sep 30, 2024 4.78 Mn
Jun 30, 2024 5.44 Mn
Mar 31, 2024 4.06 Mn
Dec 31, 2023 3.86 Mn
Sep 30, 2023 4.20 Mn
Jun 30, 2023 3.01 Mn
Mar 31, 2023 4.65 Mn
Dec 31, 2022 4.13 Mn
Sep 30, 2022 1.76 Mn
Jun 30, 2022 928,000.00
Mar 31, 2022 784,000.00
Dec 31, 2021 728,000.00
Sep 30, 2021 735,000.00
API Access

Cogent Biosciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=COGT&period=max&api_key=YOUR_API_KEY